Showing results (931-940 of 3,524) with videos related to

Sort By:
Pageof 353
Thoracic Cancer|June 16, 2022
Diagnostic pitfall in a large cell lung cancer with testicular metastasis synchronous malignant pleural mesothelioma patient: A case reportLisha Jiang, Veylenta A De Souza, Nithin M George, et al.
Thoracic Cancer|May 6, 2022
The outcomes of margin status after sleeve lobectomy for patients of non-small cell lung cancerJianghao Ren, Mingyang Zhu, Yuanyuan Xu, et al.
Thoracic Cancer|November 22, 2022
Late-onset acute type 1 diabetes mellitus 7 months after discontinuation of pembrolizumab against lung cancerSeiya Ichihara, Michihiro Kunishige, Naoki Kadota, et al.
Thoracic Cancer|November 22, 2022
Real-world treatment and prognostic factors for survival in ALK+ non-small cell lung cancer (NSCLC) patients with brain metastases in ChinaNa Li, Mingying Xie, Zichao Zhou, et al.
Thoracic Cancer|November 21, 2022
Molecular profiles of single circulating tumor cells from early breast cancer patients with different lymph node statusesShuyun Pang, Shu Xu, Lulu Wang, et al.
Thoracic Cancer|July 11, 2022
Multi-organs perioperative immune-related adverse events and postoperative bronchial anastomotic fistula in a patient receiving neoadjuvant immunotherapy with NSCLCYuan Xu, Xiaohong Lyu, Yingzhi Qin, et al.
Thoracic Cancer|June 24, 2021
Development and validation of tumor-to-blood based nomograms for preoperative prediction of lymph node metastasis in lung cancerYili Fu, Xiaoying Xi, Yanhua Tang, et al.
Thoracic Cancer|December 16, 2022
Endobronchial ultrasound-guided re-biopsy of non-small cell lung cancer with acquired resistance after EGFR tyrosine kinase inhibitor treatmentKyung Soo Hong, Jinmo Cho, Jong Geol Jang, et al.
Thoracic Cancer|January 3, 2023
The development of a tumor-associated autoantibodies panel to predict clinical outcomes for immune checkpoint inhibitor-based treatment in patients with advanced non-small-cell lung cancerJing Zhao, Yang Wu, Yuan Yue, et al.
Thoracic Cancer|January 3, 2023
Efficacy and safety of antiangiogenic agents or chemotherapy plus EGFR-TKIs in advanced non-small cell lung cancer: A systematic review and network meta-analysisJiali Dai, Xinyin Liu, Jun Li, et al.
Pageof 353